US Patent 9867876 Parenteral norovirus vaccine formulations
Patent 9867876 was granted and assigned to Takeda (company) on January, 2018 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 9867876 Parenteral norovirus vaccine formulations
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
